Online citations, reference lists, and bibliographies.
← Back to Search

The French National Mesothelioma Surveillance Program

M. Goldberg, E. Imbernon, P. Rolland, A. Soit Ilg, M. Savès, A. de Quillacq, C. Frenay, S. Chamming's, P. Arveux, C. Boutin, G. Launoy, J. Pairon, P. Astoul, F. Galateau-Sallé, P. Brochard
Published 2006 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Objectives: The French National Mesothelioma Surveillance Program (NMSP) was established in 1998 by the National Institute for Health Surveillance (InVS). Its objectives are to estimate the trends in mesothelioma incidence and the proportion attributable to occupational asbestos exposure, to help improve its pathology diagnosis, to assess its compensation as an occupational disease, and to contribute to research. Methods: The NMSP records incident pleural tumours in 21 French districts that cover a population of approximately 16 million people (a quarter of the French population). A standardised procedure of pathological and clinical diagnosis ascertainment is used. Lifetime exposure to asbestos and to other factors (man made mineral fibres, ionising radiation, SV40 virus) is reconstructed, and a case-control study was also conducted. The proportion of mesothelioma compensated as an occupational disease was assessed. Results: Depending on the hypothesis, the estimated number of incident cases in 1998 ranged from 660 to 761 (women: 127 to 146; men: 533 to 615). Among men, the industries with the highest risks of mesothelioma are construction and ship repair, asbestos industry, and manufacture of metal construction materials; the occupations at highest risk are plumbers, pipe-fitters, and sheet-metal workers. The attributable risk fraction for occupational asbestos exposure in men was 83.2% (95% CI 76.8 to 89.6). The initial pathologist’s diagnosis was confirmed in 67% of cases, ruled out in 13%, and left uncertain in the others; for half of the latter, the clinical findings supported a mesothelioma diagnosis. In all, 62% applied for designation of an occupational disease, and 91% of these were receiving workers’ compensation. Conclusions: The NMSP is a large scale epidemiological surveillance system with several original aspects, providing important information to improve the knowledge of malignant pleural mesothelioma, such as monitoring the evolution of its incidence, of high risk occupations and economic sectors, and improving pathology techniques.
This paper references
Estimation de l ’ incidence nationale du mésothéliome pleural à partir du Programme national de surveillance du mésothéliome , 1998 – 1999
P Rolland (2003)
Immunohistochemical diagnosis of mesothelioma: experience of the French mesothelioma panel
-F Galateau-Salle
Cancer incidence and mortality in France over the period 1978-2000.
L. Remontet (2003)
10.1002/ijc.11357
Incidence trends of mesothelioma in Norway, 1965–1999
B. Ulvestad (2003)
État des lieux sur les cancers professionnels en Europe, Rapport Eurogip-02/F
10.1016/S0140-6736(95)90462-X
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
Disparités régionales de la reconnaissance du mésothéliome de la plèvre comme maladie professionnelle en France (1986–1993)
M Goldberg (1999)
10.1002/AJIM.10047
Malignant mesothelioma in Australia, 1945-2000.
J. Leigh (2002)
10.1093/OXFORDJOURNALS.AJE.A009616
Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study.
Y. Iwatsubo (1998)
Immunohistochemical diagnosis of mesothelioma : experience of the French mesothelioma panel [ Mesopath Group ]
F Galateau-Sallé (2000)
10.5271/SJWEH.185
Surveillance and intervention studies on respiratory cancers in asbestos-exposed workers.
E. Merler (1997)
Occupations and industries at high risk for pleural mesothelioma: a French population-based case-control study
P Rolland (1998)
10.1023/A:1026300619747
Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends
F. Montanaro (2004)
Estimation de l'incidence nationale du mésothéliome pleural à partir du Programme national de surveillance du mésothéliome
Pnsm (1998)
Effects on health of non-occupational exposure to airborne mineral fibres.
M. J. Gardner (1989)
Effets sur la santé des principaux types d'exposition à l'amiante
D. Douguet (1997)
10.1007/978-3-642-10862-4
[Malignant mesothelioma].
J. Espinosa Arranz (1994)
Occupations and industries at high risk for pleural mesothelioma: a French population-based case-control study (1998–2002)
P Rolland (2004)
Évaluation de la prise en charge médico-sociale des mésothéliomes pleuraux
S Chammingaposs (1999)
10.1002/AJIM.10313
Malignant mesothelioma in Italy, 1997.
M. Nesti (2004)
Évaluation de la prise en charge médico-sociale des mésothéliomes pleuraux. Années 1999–2001
S Chamming’s (2003)
Prevention of respiratory diseases (Lung biology in health and disease)
J C Mcdonald (1993)
10.1097/00000478-200404000-00013
Well-differentiated Papillary Mesothelioma of the Pleura: A Series of 24 Cases
F. Galateau-Sallé (2004)
10.1002/1097-0142(19801001)46:7<1650::AID-CNCR2820460726>3.0.CO;2-Y
Malignant mesothelioma in North America
A. Mcdonald (1980)
Epidemiology of pleural cancer
J. C. Mcdonald (1993)
10.1136/oem.55.11.760
Estimation of the past and future burden of mortality from mesothelioma in France.
A. G. Ilg (1998)
[Regional differences in the compensation of pleural mesothelioma as occupational disease in France (1986-1993)].
M. Goldberg (1999)
Pleural mesothelioma: dose-response relationship at low level of asbestos exposure in a population-based casecontrol study
Y Iwatsubo (1998)
10.1136/oem.57.7.488
Future trends in mortality of French men from mesothelioma
A. Banaei (2000)
Malignant mesothelioma in Australia
A. Musk (2006)
10.1093/AJE/KWH025
Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.
B. Price (2004)



This paper is referenced by
10.1002/ajim.20705
Under-reporting of compensable mesothelioma in Alberta.
M. Cree (2009)
10.1136/oem.2009.048629
Surveillance of mesothelioma and workers' compensation in British Columbia, Canada
Tracy L Kirkham (2010)
10.1007/978-3-030-16884-1_1
Epidemiology of Mesothelioma
D. Mirabelli (2019)
10.1684/SSS.2010.0205
Les fibres courtes d'amiante sont-elles toxiques ? Production de connaissances scientifiques et maladies professionnelles
A. Thébaud-Mony (2010)
10.1007/978-3-319-53560-9_5
Communities at High Risk in the Third Wave of Mesothelioma
E. Emmett (2017)
10.1016/j.healthpol.2020.06.005
Predictors of filing claims and receiving compensation in malignant mesothelioma patients.
A. Marinaccio (2020)
10.3892/mco.2020.2131
Malignant mesothelioma metastatic to the oral region and latest topics (Review).
Y. Ohnishi (2020)
10.1016/j.ejca.2020.09.011
Mesothelioma in children and adolescents: the European Cooperative Study Group for Pediatric Rare Rumors (EXPeRT) contribution.
D. Orbach (2020)
10.5858/arpa.2018-0457-OA
Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic Practice.
N. Le Stang (2019)
10.1038/bjc.2012.113
Occupational cancer in Britain
S. Hutchings (2012)
10.1136/oem.2009.050336
Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates
S. Goldberg (2010)
10.1155/2016/5340676
Software for Apportionment of Asbestos-Related Mesotheliomas
R. Ross (2016)
10.1136/thoraxjnl-2013-203744
Occupational and non-occupational attributable risk of asbestos exposure for malignant pleural mesothelioma
A. Lacourt (2014)
10.1016/j.prp.2020.152817
Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma.
M. Matsuda (2020)
10.1002/ijc.26229
Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register
A. Marinaccio (2012)
10.17305/BJBMS.2008.2898
Malignant pleural mesothelioma treated in Clinic for Pulmonary Diseases and Tuberculosis "Podhrastovi" in ten-year period (from 1998 to 2007).
V. Čukić (2008)
10.1183/09031936.00094008
Pleural plaques and asbestosis: dose– and time–response relationships based on HRCT data
C. Paris (2009)
10.1289/ehp.0900868
Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?
L. A. Tse (2010)
10.1002/ajim.20874
Surveillance of fatal occupational injuries in France: 2002-2004.
J. Brière (2010)
10.1051/RADIOPRO/2017015
Mortality in the French cohort of nuclear workers
K. Leuraud (2017)
10.1002/jcp.22724
Malignant mesothelioma: Facts, Myths, and Hypotheses
M. Carbone (2012)
10.1183/09031936.00005111
Temporal patterns of occupational asbestos exposure and risk of pleural mesothelioma
A. Lacourt (2011)
Geographical patterns of mesothelioma incidence and asbestos exposure in Lombardy, Italy.
C. Mensi (2016)
Pairon Cancers respiratoires professionnels
J. Pairon (2008)
10.1159/000503239
Diagnostic Value of Computed Tomography Imaging Features in Malignant Pleural Mesothelioma
M. Fortin (2019)
10.1038/sj.bjc.6604879
Occupational, domestic and environmental mesothelioma risks in the British population: a case–control study
C. Rake (2009)
10.1002/ajim.22065
A decade of malignant mesothelioma surveillance in Korea.
Soon-Hee Jung (2012)
10.1186/1471-2458-12-314
Mesothelioma incidence surveillance systems and claims for workers’ compensation. Epidemiological evidence and prospects for an integrated framework
A. Marinaccio (2012)
In fl ammation-Related IL 1 b / IL 1 R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma
Yuwaraj Kadariya (2016)
10.1016/j.jtho.2016.04.028
Consensus Report of the 2015 Weinman International Conference on Mesothelioma
M. Carbone (2016)
10.1007/978-1-4471-2825-0_13
Malignant Mesothelioma: Epidemiology
P. Boffetta (2014)
10.2353/ajpath.2009.080352
SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.
T. Henzi (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar